James Mulshine to Drug Design
This is a "connection" page, showing publications James Mulshine has written about Drug Design.
Connection Strength
1.060
-
Application of high-resolution CT imaging data to lung cancer drug development: measuring progress: workshop IX. J Thorac Oncol. 2013 Nov; 8(11):1352-5.
Score: 0.446
-
Use of high-resolution CT imaging data in lung cancer drug development: measuring progress. Oncology (Williston Park). 2009 Apr 30; 23(5):434-8.
Score: 0.326
-
Fostering chemopreventive agent development: how to proceed? J Cell Biochem Suppl. 1995; 22:254-9.
Score: 0.121
-
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets. Bioinformatics. 2008 Feb 01; 24(3):389-95.
Score: 0.073
-
Developing CT image-processing tools to accelerate progress in lung cancer drug development. Oncology (Williston Park). 2006 Nov; 20(12):1606, 1608-10, 1614 passim.
Score: 0.069
-
Growth factors and other targets for rational application as intervention agents. Adv Exp Med Biol. 1992; 320:81-8.
Score: 0.025